What is considered a severely reduced left ventricular ejection fraction (LVEF)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Definition of Severely Reduced Left Ventricular Ejection Fraction

A left ventricular ejection fraction (LVEF) below 30% is considered severely reduced according to current clinical guidelines.

Classification of Left Ventricular Ejection Fraction

The European Society of Cardiology (ESC) classifies heart failure based on LVEF as follows:

  • HFrEF (Heart Failure with reduced Ejection Fraction): LVEF < 40%
  • HFmrEF (Heart Failure with mildly reduced Ejection Fraction): LVEF 40-49%
  • HFpEF (Heart Failure with preserved Ejection Fraction): LVEF ≥ 50%

Within the HFrEF category, LVEF < 30% is specifically recognized as severely reduced ejection fraction 1.

Clinical Significance of Severely Reduced LVEF

Severely reduced LVEF (< 30%) has important clinical implications:

  • Mortality risk: Patients with LVEF < 30% have significantly higher mortality rates compared to those with higher ejection fractions

  • Treatment decisions: Several therapeutic interventions are specifically indicated for patients with LVEF < 30%:

    • Combined surgery for secondary mitral regurgitation and coronary artery bypass grafting should be considered in symptomatic patients with LVEF < 30% requiring coronary revascularization 1
    • Isolated surgery for non-ischemic regurgitant mitral valve in patients with severe functional mitral regurgitation and LVEF < 30% may be considered in selected patients 1
  • Mode of death: When LVEF is severely depressed (< 15-20%), the prevailing mode of cardiac death is often non-sudden, or when sudden, it is frequently related to bradyarrhythmias or electromechanical dissociation rather than ventricular tachyarrhythmias 1

Prognostic Implications

The relationship between LVEF and prognosis is not always linear:

  • Once LVEF falls below 20%, it may no longer be a strong predictor of mortality, as other factors such as peak VO₂ become more important prognostic indicators 2
  • LVEF has a strong dose-dependent relationship with right ventricular ejection fraction (RVEF), with LVEF < 17% associated with significantly higher odds of abnormally low RVEF (< 20%) 3

Clinical Considerations

When managing patients with severely reduced LVEF:

  • Early intervention: Consider that LVEF deterioration often begins before conditions like aortic stenosis become severe, and accelerates after valve area reaches critical thresholds 4
  • Monitoring: Patients with LVEF ≤ 55% and ischemic etiology are at higher risk of transitioning from preserved to reduced ejection fraction over time 5
  • Treatment optimization: Evidence-based medical therapy including ACE inhibitors like lisinopril has been shown to improve outcomes in patients with reduced LVEF 6

Key Takeaway

While various thresholds exist in different contexts, an LVEF < 30% is consistently recognized as severely reduced across major cardiovascular guidelines and has significant implications for treatment decisions and prognosis.

Related Questions

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.